These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21572705)

  • 1. Hemolytic disease of the fetus and newborn: Current trends and perspectives.
    Basu S; Kaur R; Kaur G
    Asian J Transfus Sci; 2011 Jan; 5(1):3-7. PubMed ID: 21572705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis.
    Ayenew AA
    Matern Health Neonatol Perinatol; 2021 Feb; 7(1):8. PubMed ID: 33531050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Unusual Case of Hemolytic Disease of Newborn Due to ABO and Rh Isoimmunization.
    Routray SS; Sahoo JP; Behera R; Acharya D; Kanungo GN
    Cureus; 2020 Dec; 12(12):e12121. PubMed ID: 33489535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, Specificity and Titration of Red Cell Alloantibodies in Multiparous Antenatal Females at a Tertiary Care Centre from North India.
    Sidhu M; Bala R; Akhtar N; Sawhney V
    Indian J Hematol Blood Transfus; 2016 Sep; 32(3):307-11. PubMed ID: 27429523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria.
    Jeremiah ZA; Mordi A; Buseri FI; Adias TC
    Asian J Transfus Sci; 2011 Jan; 5(1):39-41. PubMed ID: 21572714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell alloimmunization in pregnancy: a study from a premier tertiary care centre of Western India.
    Gothwal M; Singh P; Bajpayee A; Agrawal N; Yadav G; Sharma C
    Obstet Gynecol Sci; 2023 Mar; 66(2):84-93. PubMed ID: 36444517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic Disease of Fetus and Newborn in a Primigravida with Multiple Alloantibodies Involving Anti-Jk
    Iberahim S; Aizuddin MJ; Kadir NA; Rameli N; Adzahar S; Noor NHM; Abdullah WZ
    Oman Med J; 2020 Nov; 35(6):e206. PubMed ID: 33335745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi.
    Pahuja S; Gupta SK; Pujani M; Jain M
    Blood Transfus; 2011 Oct; 9(4):388-93. PubMed ID: 21839025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.
    Zwiers C; Koelewijn JM; Vermij L; van Sambeeck J; Oepkes D; de Haas M; van der Schoot CE
    Transfusion; 2018 Jul; 58(7):1611-1617. PubMed ID: 29624682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cell alloimmunization among antenatal women attending tertiary care center in Jamnagar, Gujarat, India.
    Dholakiya SK; Bharadva S; Vachhani JH; Upadhyay BS
    Asian J Transfus Sci; 2021; 15(1):52-56. PubMed ID: 34349457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report.
    Yousuf R; Abdul Aziz S; Yusof N; Leong CF
    J Med Case Rep; 2012 Feb; 6():71. PubMed ID: 22348809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of anti-D alloantibodies among pregnant women in Kasese District, Western Uganda.
    Mbalibulha Y; Muwanguzi E; Mugyenyi GR; Natukunda B
    J Blood Med; 2015; 6():125-9. PubMed ID: 25945071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Red Cell Alloantibodies in Pregnant Females of Navsari District: An Experience that Favours Inclusion of Screening for Irregular Erythrocyte Antibody in Routine Antenatal Testing Profile.
    Kahar M
    J Obstet Gynaecol India; 2018 Aug; 68(4):300-305. PubMed ID: 30065546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
    Hendrickson JE; Delaney M
    Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.